Skip to content
Engineering, Medical Health Aged Care

Solar panels in your eyeballs? This engineer is looking into it

UNSW Sydney 3 mins read

UNSW engineers are examining ways that solar panels can be implanted in the human retina to restore sight.


Neuroprosthetics – or devices designed to interact with the nervous system to restore lost functionality – is a developing area of research that has the potential to vastly improve quality of life.

One of the best-known examples is the cochlear implant which converts sound into electric signals that directly stimulate the auditory nerve in people with severe hearing loss.

But could the same be done for the human eye to restore vision for people with damaged photoreceptors – the cells responsible for detecting light and colour? A multidisciplinary group of researchers across the globe including engineers, neuroscientists, clinicians and other biotech experts believe it can – but it’s a case of baby steps for now.

UNSW researcher Dr Udo Roemer is an engineer who specialises in photovoltaics, known more commonly as solar panel technology. He is in the early stages of researching how solar technology can be used to convert light entering the eye into electricity, bypassing the damaged photoreceptors to transmit visual information to the brain.

“People with certain diseases like retinitis pigmentosa and age-related macular degeneration slowly lose their eyesight as photoreceptors at the centre of the eye degenerate,” Dr Roemer says.

“It has long been thought that biomedical implants in the retina could stand in for the damaged photoreceptors. One way to do it is to use electrodes to create voltage pulse that may enable people to see a tiny spot.

“There have already been trials with this technology. But the problem with this is they require wires going into the eye, which is a complicated procedure.”


Wireless option

But an alternative idea is to have a tiny solar panel attached to the eyeball that converts light into the electric impulse that the brain uses to create our visual fields. The panel would be naturally self-powered and portable, doing away for the need to have cables and wires into the eye.

Dr Roemer isn’t the first to investigate the use of solar cells assisting in restoring sight. But rather than focus on silicon-based devices, he has turned his attention to other semiconductor materials such gallium arsenide and gallium indium phosphide, mainly because it’s easier to tune the materials’ properties. It’s also used in the solar industry at large to make much more efficient solar panels, although it’s not as cheap as the all-purpose silicon.

“In order to stimulate neurons, you need a higher voltage than what you get from one solar cell,” Dr Roemer says.

“If you imagine photoreceptors being pixels, then we really need three solar cells to create enough voltage to send to the brain. So we’re looking at how we can stack them, one on top of the other, to achieve this.

“With silicon this would have been difficult, that’s why we swapped to gallium arsenide where it’s much easier.”

So how far along is this research? Dr Roemer says it’s in the proof-of-concept stage.

“So far we’ve successfully put two solar cells on top of each other in the lab on a large area – about 1cm2, which has got some good results.”

The next step will be to make them into the tiny pixels required for sight, and etching the grooves to separate them. It will then be a small step to increase the stack to three solar cells.

Dr Roemer envisages by the time this technology will be able to be tested in humans – after extensive testing in the lab, followed by testing in animal models – the device will be about 2 mm2 in size with pixels measuring about 50 micrometres (five hundredths of a millimetre). He stresses that it’s still a way down the track before this technology will be implantable in the retinas of people with degenerative eye diseases.

“One thing to note is that even with the efficiencies of stacked solar cells, sunlight alone may not be strong enough to work with these solar cells implanted in the retina,” he says.

“People may have to wear some sort of goggles or smart glasses that work in tandem with the solar cells that are able to amplify the sun signal into the required intensity needed to reliably stimulate neurons in the eye.”

Contact details:

Lachlan Gilbert

UNSW News & Content

t: +61 404 192 367


More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 19/04/2024
  • 06:00
Leukaemia Foundation

Hon. Anna Bligh AC Joins Leukaemia Foundation as National Ambassador: A Decade in Remission from Blood Cancer

The Leukaemia Foundation today unveiled a powerful addition to its team of Ambassadors, the Honourable Anna Bligh AC. As the former Premier of Queensland…

  • Contains:
  • Community, Medical Health Aged Care
  • 18/04/2024
  • 22:00
Hepatitis NSW

Hepatitis NSW supports World Liver Day with launch of new website highlighting liver health

Hepatitis NSW has joined the worldwide movement to celebrate World Liver Day on Friday, 19 April 2024. World Liver Day aims to raise awareness about the importance of liver health. The liver is one of the most important organs in your body and is also one of the largest. The liver is an essential organ that performs over 500 functions, in doing so it supports the stomach, the heart and the blood. Specifically, it cleans blood, breaks down food, stores energy and vitamins, sends energy and vitamins to the parts of the body where it is all needed, clots the…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 18/04/2024
  • 15:08
Leukaemia Foundation

The biggest challenge of cancer patients that nobody talks about… How the Leukaemia Foundation is combatting cancer related fatigue

It’s the number one challenge of people with cancer in Australia[i], yet ‘cancer related fatigue’ is the often-unspoken side effect that drains and debilitates thousands of Australians every day. With approximately one in two cancer patients reportedly experiencing moderate to severe fatigue during treatment[ii], and for many in the years following, the Leukaemia Foundation believes the prevalence of cancer related fatigue could be much higher. According to CEO, Chris Tanti, with the incidence of blood cancer continuing to soar (by 47% in the last decade[iii]), this means at least 70,000 Australians living with the disease are facing a daily battle…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.